Genotyping of RHD by multiplex polymerase chain reaction analysis of six RHD-specific exons

Transfusion

Volumn 38, Issue 11-12, 1998, Pages 1015-1021

  Maaskant Van Wijk, P A ^a   Faas, B H W ^b   De Ruijter, J A M ^c   Overbeeke, M A M ^d   Von Dem Borne, A E G Kr ^b,e   Van Rhenen, D J ^c,f   Van Der Schoot, C E ^b  

^a Bloodbank Rotterdam   (Netherlands)

^b CENTRAL LABORATORY   (Netherlands)

^c CLB ^*

^d CLB

^e ACADEMIC MEDICAL CENTER   (Netherlands)

^f ERASMUS MEDICAL CENTER   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

HEMOGLOBIN VARIANT;

AMINO ACID SUBSTITUTION; ARTICLE; BLOOD GROUP RHESUS SYSTEM; EXON; GENOTYPE; HUMAN; HUMAN CELL; PHENOTYPE; POINT MUTATION; POLYMERASE CHAIN REACTION; RHESUS INCOMPATIBILITY;

EID: 0031768108     PISSN: 00411132     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1537-2995.1998.38111299056309.x     Document Type: Article

References (33)

1. Cherif-Zahar B, Mattel MG, Le Van Kim C, et al. Localization of the human Rh blood group gene structure to chromosome 1p34.3-1p36.1 region by in situ hybridization. Hum Genet 1991;86:398-400.
2. Smythe JS, Avent ND, Judson PA, et al. Expression of RHD and RHCE gene products using retroviral transduction of K562 cells establishes the molecular basis of Rh blood group antigens. Blood 1996;87:2968-73.
3. Le Van Kim C, Cherif-Zahar B, Raynal V, et al. Multiple Rh messenger RNA isoforms are produced by alternative splicing. Blood 1992;80:1074-8.
4. Colin Y, Cherif-Zahar B, Le Van Kim C, et al. Genetic basis of the RhD-positive and RhD-negative blood group polymorphism as determined by Southern analysis. Blood 1991;78:2747-52.
5. Hyland CA, Wolter LC, Saul A. Three unrelated Rh D gene polymorphisms identified among blood donors with Rhesus CCee (r′r′) phenotypes. Blood 1994;84:321-4.
6. Umenishi F, Kajii E, Ikemoto S. Molecular analysis of Rh polypeptides in a family with RhD-positive and RhD-negative phenotypes. Biochem J 1994;299:207-11.
7. Faas BHW, Beckers EAM, Wildoer P, et al. Molecular background of VS and weak C expression in blacks. Transfusion 1997;37:38-44.
8. Blunt T, Daniels G, Carrit B. Serotype switching in a partially detected RHD gene. Vox Sang 1994;67:397-401.
9. u), and partial D phenotypes as determined by multiplex polymerase chain reaction analysis of die RHD gene. Blood 1997;89:2568-77.
10. Daniels G, Green C, Smart E. Differences between RhD-negative Africans and RhD-negative Europeans (letter). Lancet 1997;350:862-3.
11. Okuda H, Kawano M, Iwamoto S, et al. The RHD gene is highly detectable in RhD-negative Japanese donors. J Clin Invest 1997;100:373-9.
12. Beckers EAM, Faas BHW, Ligthart P, et al. Lower antigen site density and weak D immunogenicity cannot be explained by structural genomic abnormalities or regulatory defects of the RHD gene. Transfusion 1997;37:616-23.
13. N phenotypes. Blood 1996;87:4853-61.
14. Faas BH, Beckers EA, Maaskant-van Wijk PA, et al. Molecular characterization of qualitative Rh variants. Biotest Bull 1997;5:439-49.
15. Jones J, Finning K, Mattock R, et al. The serological profile and molecular basis of a new partial D phenotype, DHR. Vox Sang 1997;73:252-6.
16. Flegel WA, Wagner FF. The frequency of RHD protein variants in Caucasians (abstract). Transfus Clin Biol 1996;3:10s.
17. Bennett PR, Le Van Kim C, Colin Y, et al. Prenatal determination of fetal RhD type by DNA amplification. N Engl J Med 1993;329:607-10.
18. Arce MA, Thompson ES, Wagner S, et al. Molecular cloning of RhD cDNA derived from a gene present in RhD-positive, but not RhD-negative individuals. Blood 1993;82:651-5.
19. Wolter LC, Hyland CA, Saul A. Rhesus D genotyping using polymerase chain reaction (letter). Blood 1993;82:1682-3.
20. Simsek S, Faas BH, Bleeker PM et al. Rapid Rh D genotyping by polymerase chain reaction-based amplification of DNA. Blood 1995;85:2975-80.
21. Pope J, Navarrete C, Warwick R, Contreras M. Multiplex PCR analysis of RhD gene (letter). Lancet 1995;346:375-6.
22. Aubin JT, Le Van Kim C, Mouro I, et al. Specificity and sensitivity of RHD genotyping methods by PCR-based DNA amplification. Br J Haematol 1997;98:356-64.
23. Rouillac C, Le Van Kim C, Beolet M, et al. Leu110Pro substitution in the RhD polypeptide is responsible for the DVII category blood group phenotype. Am J Hematol 1995;49:87-8.
24. Maaskant-Van Wijk PA, Faas BH, Wildoer P, et al. Rh DNA analysis. Transfus Clin Biol 1996;3:507-10.
25. Beckers EAM, Faas BHW, Ligthart PC et al. Characterization of the hybrid RHD gene leading to the partial D category IIIc phenotype. Transfusion 1996;36:567-74.
26. VI category phenotype. Blood 1994;83:1129-35.
27. VI deletion genotype does not exist (letter). Blood 1997;90:1709-11.
28. DBT. Br J Haematol 1996;93:720-7.
29. Faas BHW, Beckers EAM, Simsek S, et al. Involvement of Ser103 of the Rh polypeptides in G epitope formation. Transfusion 1996;36:506-11.
30. Simsek S, Bleeker PM, von dem Borne AE. Prenatal determination of fetal RhD type (letter). N Engl J Med 1994;330:795-6.
31. Carritt B, Steers FJ, Avent ND. Prenatal determination of fetal RhD type (letter). Lancet 1994;344:205-6.
32. Urbaniak SJ, Cochrane S, Armstrong-Fisher SS, Clark D. The identification of discrepancies between serological and genotypic assignment of RhD status using polymerase chain reaction (PCR) (abstract). Transfusion 1995;35(Suppl):51S.
33. Huang CH. Alteration of RH gene structure and expression in human dCCee and DCW-red blood cells: phenotypic homozygosity versus genotypic heterozygosity. Blood 1996;88:2326-33.